The Carcinoembryonic Antigen (CEA) Rapid Test is a professional-grade diagnostic tool designed for the qualitative detection of CEA in human serum, plasma, or whole blood. By utilizing advanced immunochromatographic technology, this test provides a critical screening mechanism for monitoring specific health markers with clinical precision.
Engineered for efficiency and reliability, the CEA Rapid Test eliminates the need for complex laboratory instrumentation, delivering high-accuracy results within minutes. It serves as an essential resource for medical professionals seeking a fast, sensitive, and specific method for patient screening and health monitoring.
Detailed Parameters
| Test Item | Carcinoembryonic Antigen (CEA) | Specimen Type | Serum, Plasma, or Whole Blood |
|---|---|---|---|
| Product Model (Cassette) | CEA-C30 (3.0mm) | Product Model (Strip) | CEA-S25 (2.5mm) |
| Test Format | Rapid Test Cassette / Strip | Processing Time | 15 Minutes |
| Storage Temperature | 2-30°C | Storage Condition | Sealed foil pouch, do not freeze |
| Kit Components | Test devices, droppers, Lysis buffer | Device Quantity | 25 tests per kit |
Key Advantages
High Clinical Accuracy
Delivers exceptional specificity and sensitivity to ensure reliable diagnostic results for medical screening.
Rapid Turnaround
Obtain clear, actionable results in just 15 minutes, significantly reducing patient waiting time.
Instrument-Free
No expensive laboratory machinery required, making it ideal for point-of-care testing (POCT).
Easy Interpretation
Visual result readout is intuitive and straightforward, requiring no complex data processing.
Versatile Sampling
Compatible with serum, plasma, and whole blood specimens to accommodate various clinical needs.
Stable Storage
Optimized for stability between 2-30°C, ensuring product integrity until the expiry date.
Product Gallery
Management Platforms
Supply Chain Optimization
Streamlined logistics for medical consumables to ensure timely delivery to healthcare facilities.
Quality Control Systems
Strict adherence to medical device manufacturing standards to guarantee batch-to-batch consistency.
Regulatory Compliance
Ensuring all diagnostic kits meet international medical safety and performance certifications.
Inventory Management
Advanced tracking of expiry dates and storage conditions to maintain maximum kit efficacy.
Scalable Production
High-capacity manufacturing lines for rapid tests to meet global health demands.
Technical Support
Professional guidance on specimen processing and result interpretation for clinicians.
Investment Return Comparison
| Feature | Traditional Lab Test | Rapid Test Cassette |
|---|---|---|
| Result Time | 24-72 Hours | 15 Minutes |
| Equipment Cost | High Investment | Zero Instrument Cost |
| Operational Complexity | Requires Specialist | Simple Manual Process |
| Patient Experience | Repeated Visits | Immediate On-site Result |
| Cost per Test | Higher (Labor+Energy) | Optimized Low Cost |
Frequently Asked Questions
The CEA Rapid Test is used for the qualitative detection of Carcinoembryonic Antigen, which is primarily utilized as a tumor marker for screening and monitoring specific health conditions.
The kits must be stored between 2-30°C. It is critical to keep the devices in their sealed foil pouches until the moment of use and avoid freezing them.
The test is designed to work efficiently with human serum, plasma, or whole blood specimens.
No, no laboratory equipment is required to process the specimen or read the results, making it ideal for rapid point-of-care testing.
The results are typically available and ready for interpretation within 15 minutes of sample application.
Each kit contains 25 sealed test devices (with desiccants), 25 mini plastic droppers, one bottle of Blood Lysis buffer (10 mL), and a detailed package insert.